On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice

被引:14
作者
Caballero, F
Gerez, E
Oliveri, L
Falcoff, N
Batlle, A
Vazquez, E
机构
[1] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, CIPYP, RA-1428 Buenos Aires, DF, Argentina
[2] Hosp Dr Bernardo Houssay, Dept Pathol, Buenos Aires, DF, Argentina
关键词
hepatocarcinogenesis; tamoxifen; p-dimethylaminoazobenzene; cytochrome P450; oxidative stress;
D O I
10.1016/S1357-2725(01)00056-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background and aims: Tamoxifen (TMX) has proven to be an effective palliative treatment for advanced breast cancer with low reported incidence of side effects. TMX has been demonstrated to be: an initiator and/or a promoter in the rat model of hepatocarcinogenesis. To document the long-term effect of TMX in mice treated with p-dimerhylaminuazobenzene (DAB), we have investigated the time response action of these drugs on different biochemical parameters. Methods: A group of animals was placed on dietary DAB (0.5%, w/w) during a period of 28 weeks. Control animals received a standard laboratory diet. Two other groups of non-treated and DAB-treated animals received TMX citrate (0.025%. w/w) in the diet since day 20. Results: The activities of the enzymes involved in heme synthesis and degradation as evaluated in the DAB group was not further affected by TMX. DAB and/or TMX treatment significantly increased the content of total cytochrome P450 and also the activity of glutathione S-transferase indicating liver damage. In all treated groups oxidative stress and an adaptive response of the natural defense system (catalase and superoxide dismutase) were demonstrated. Histological and morphological studies revealed liver cell hyperplasia in DAB treated group: however. only in the DAB + TMX group solid. trabecular and acinar hepatocellular carcinoma was confirmed at the end of the experimental trial. Conclusions: We have demonstrated that TMX produced changes in hepatic enzyme activities which may be relevant fur the metabolism and disposition of this and/or other drugs. Because liver tumors could be initiated and promoted by several agents which need to be activated. the possible hazard of TMX should be considered. This study reports that long-term treatment with TMX enhances hepatocarcinogenesis induced by DAB. The widespread use of TMX as an anticancer agent adds to the significance of this study. (C) 2001 Published by Elsevier Science Ltd.
引用
收藏
页码:681 / 690
页数:10
相关论文
共 32 条
[1]  
[Anonymous], [No title captured]
[2]  
CARTHEW P, 1995, CANCER RES, V55, P544
[3]   ASSAY OF CATALASES AND PEROXIDASES [J].
CHANCE, B ;
MAEHLY, AC .
METHODS IN ENZYMOLOGY, 1955, 2 :764-775
[4]   STUDIES OF TAMOXIFEN AS A PROMOTER OF HEPATOCARCINOGENESIS IN FEMALE FISCHER F344 RATS [J].
DRAGAN, YP ;
FAHEY, S ;
STREET, K ;
VAUGHAN, J ;
JORDAN, VC ;
PITOT, HC .
BREAST CANCER RESEARCH AND TREATMENT, 1994, 31 (01) :11-25
[5]   The effect of tamoxifen and two of its non-isomerizable fixed-ring analogs on multistage rat hepatocarcinogenesis [J].
Dragan, YP ;
Fahey, S ;
Nuwaysir, E ;
Sattler, C ;
Babcock, K ;
Vaughn, J ;
McCague, R ;
Jordan, VC ;
Pitot, HC .
CARCINOGENESIS, 1996, 17 (03) :585-594
[6]  
*EARL BREAST CANC, 1992, LANCET, V339, P1
[7]   NEW PERSPECTIVE ON CANCER OF THE CONTRALATERAL BREAST - A MARKER FOR ASSESSING TAMOXIFEN AS A PREVENTIVE AGENT [J].
FISHER, B ;
REDMOND, C .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (18) :1278-1280
[8]   Altered heme pathway regulation and drug metabolizing enzyme system in a mouse model of hepatocarcinogenesis: Effect of veronal [J].
Gerez, E ;
Vazquez, E ;
Caballero, F ;
Polo, C ;
Batlle, A .
GENERAL PHARMACOLOGY, 1997, 29 (04) :569-573
[9]  
Gerez E, 1998, EUR J CANCER PREV, V7, P69
[10]   INDUCTION AND PROMOTION OF GAMMA-GLUTAMYLTRANSPEPTIDASE-POSITIVE FOCI IN THE LIVER OF FEMALE RATS TREATED WITH ETHINYL ESTRADIOL, CLOMIPHENE, TAMOXIFEN AND THEIR ASSOCIATIONS [J].
GHIA, M ;
MERETO, E .
CANCER LETTERS, 1989, 46 (03) :195-202